Consistent with this, it has been shown that mucosal administration of Hsp65-induced Tregs in several models of chronic inflammatory conditions such as atherosclerosis (29), rheumatoid arthritis (26), and diabetes (27). Here, HSPD1 is linked to diabetes mellitus.